✦ LIBER ✦

A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer

✍ Scribed by Ambros, Tadeu; Zeichner, Simon B.; Zaravinos, John; Montero, Alberto J.; Ahn, Eugene; Aruna, Mani; Kronish, Lori; Mahtani, Reshma L.; Vogel, Charles L.

Book ID: 125356849
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 202 KB
Volume: 146
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-014-3003-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metronomic oral combination chemotherapy

Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer

✍ Masataka Yoshimoto, Shintaro Takao, Masaru Hirata… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 245 KB

A multicentre phase II study to evaluate

A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer

✍ Juan Bayo; María Lomas; Javier Salvador; Alberto Moreno; Manuel Ruiz; Alberto Ro 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 332 KB

A Phase II Trial of Split, Low-Dose Doce

A Phase II Trial of Split, Low-Dose Docetaxel and Low-Dose Capecitabine: A Tolerable and Efficacious Regimen in the First-Line Treatment of Patients with HER2/neu–Negative Metastatic Breast Cancer

✍ Orlando Silva; Gilberto Lopes; Daniel Morgenzstern; Christopher Lobo; Philomena 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB

Low dose capecitabine plus weekly paclit

Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609

✍ Tetsuya Taguchi, Daigo Yamamoto, Norikazu Masuda… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 231 KB

PO56 TRIPLE NEGATIVE AND HORMONE-NEGATIV

PO56 TRIPLE NEGATIVE AND HORMONE-NEGATIVE/HER2-POSITIVE BREAST CANCER: WHICH THE WORST FOR WOMEN WITH METASTATIC DISEASE? A MONO-INSTITUTIONAL RETROSPECTIVE ANALYSIS ON 460 PATIENTS

✍ Palumbo, Raffaella; Sottotetti, Federico; Riccardi, Alberto; Pozzi, Emma; Teragn 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Phase II trial of a novel capecitabine d

Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB